IP Verse

Treatment Of Hair Loss Disorders With Deuterated Jak Inhibitors

Patent No. EP3452039 (titled "Treatment Of Hair Loss Disorders With Deuterated Jak Inhibitors") was filed by Concert Pharmaceuticals on May 4, 2017. The application was issued on Jul 3, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BIOFRONTERA BIOSCIENCEApr 3, 2025KANZLEITER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3452039

CONCERT PHARMACEUTICALS
Application Number
EP17793380A
Filing Date
May 4, 2017
Status
Granted And Under Opposition
May 31, 2024
Publication Date
Jul 3, 2024
External Links
Slate, Register , Google Patents